| Ovidrel (choriogonadotropin alfa) / EMD Serono |
2006-000194-29: In Vitro Maturation (IVM) as part of the treatment of infertility in women with polycystic ovaries (PCO).Is priming with hCG favourable? A prospective randomized study. |
|
|
| Ongoing | 4 | 200 | Europe | Ovitrelle, hCG, Ovitrelle, Ovitrelle | Fertility Clinic, dept. of Obstetrics and gynecology, OUH. | Infertility in women with polycystic ovaries (PCO). | | | | |
2011-003250-34: Endometrial receptivity with different support protocols for the luteal phase in ovarian stimulation cycles in which final oocyte maturation is carried out with GnRH analogues. Analysis by endometrial microarrays. Receptividad endometrial con diferentes protocolos de soporte de fase lútea en ciclos de estimulación ovárica en los que la maduración final ovocitaria se realiza con análogos de la GnRH. Análisis mediante microarrays de endometrio. |
|
|
| Ongoing | 4 | 25 | Europe | Progynova, UTROGESTAN, Luveris, Ovitrelle, Progynova, UTROGESTAN, Luveris, Ovitrelle | IVI Madrid, Merck Sharp & Dohme de España, SA | Ovarian Hyperstimulation Syndrome (OHSS) Síndrome de Hiperestimulación Ovárica (SHO) | | | | |
2020-001218-39: Estradiol levels in early pregnancy after natural, estradiol + progesterone or gonadotrophin stimulated frozen embryo transfer (FET) cycle Østradiol-niveauer i tidlig graviditet efter naturlig, østradiol + progesteron eller gonadotropin-stimuleret frysecyklus. |
|
|
| Not yet recruiting | 4 | 300 | Europe | estradiol, bemfola, cyclogest, ovitrelle, 30158EU/1/00/165/007( marketing code), Tablet, Solution for injection/infusion, Vaginal tablet, Suspension for injection in pre-filled pen, Estradiol, bemfola, Cyclogest, ovitrelle | fertility clinic, Herlev university hospital, Fertilti clinic Hvidovre University hospital, Fertility clinic Herlev University Hospital, Fertility clinic Hvidovre University Hospital | Infertile women Infertile kvinder, Infertile women Ufrivilligt barnløse kvinder, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2021-002467-22: Dual Trigger for Elective Fertility Preservation Doble descarga en preservación de fertilidad social |
|
|
| Ongoing | 4 | 100 | Europe | Solution for injection, , Decapeptyl diario 0,1 mg polvo y disolvente para solución inyectable, Ovitrelle 250 microgramos solución inyectable en pluma precargada. | Fundacion Santiago Dexeus Font, Fundación Santiago Dexeus Font | This study is a randomized controlled, superiority trial comparing the number of MII oocytes following final follicle maturation with dual trigger (250 μg rhCG + 0.2mg Triptorelin) or GnRH-a trigger (0.2mg Triptorelin) in women undergoing elective fertility preservation. Este estudio es un estudio controlado aleatorizado de superioridad para comparar el número de ovocitos MII tras maduración folicular con doble descarga (250 μg rhCG + 0.2mg Triptorelin) o descarga con GnRH-a (0.2mg Triptorelin) en mujeres que realizan preservación de fertilidad social, To compare the number of mature oocytes (MII) retrieved after dual trigger and GnRH-a trigger in patients undergoing elective fertility preservation in a progestin-primed ovarian stimulation protocol. Comparar el número de ovocitos MII recuperados tras doble descarga y descarga simple con GnRH-a en pacientes que siguen preservación social en un protocolo de estimulación ovárica controlada, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2021-000941-42: INTEnsity of ovariaN Stimulation and Embryo Quality Intensidad de la estimulación ovárica y calidad embrionaria |
|
|
| Ongoing | 4 | 100 | Europe | Solution for injection in pre-filled pen, Solution for injection, Capsule, soft, , Ovaleap 900 UI/1,5 ml solucion inyectable, Ovaleap 450 UI/0,75 ml solucion inyectable, Ovaleap 300 UI/0,5 ml solucion inyectable, Orgalutran 0,25 mg/0,5 ml solución inyectable, Ovitrelle 250 microgramos solución inyectable en pluma precargada., Decapeptyl diario 0,1 mg polvo y disolvente para solución inyectable, utrogestan 200 mg cápsulas blandas, Omifin 50 mg comprimidos | Fundacion Santiago Dexeus Font, Fundación Santiago Dexeus Font | To compare the number of GQB and the morphokinetic parameters of early embryo development in infertile suboptimal patients undergoing two different intensities of ovarian stimulation, a milder approach ( Clomiphene Citrate (CC) 50mg/day plus 150IU daily dose of rFSH) and a more intense approach (300IU daily dose of rFSH). Comparar el número de embriones buena calidad y los parámetros morfocinéticos de desarrollo temprano de embriones en pacientes infértiles subóptimas sometidas a dos intensidades de estimulación ovárica diferentes, una más suave (Citrato de Clomifeno más 150 UI FSHr diariamente) y una mas intensa (300 UI FSHr diariamente), To compare the two stimulation groups of Clomiphene Citrate (CC) 50mg/day plus rFSH 150IU vs. 300IU regarding the number of good quality blastocysts (GQB) in suboptimal patients. Comparar los dos grupos de estimulación de Citrato de Clomifeno más 150 UI FSHr vs. 300UI FSHr en cuanto al número de blastocistos de buena calidad en pacientes subóptimas, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2020-002453-26: Eight weeks of pre-treatment with hCG before in vitro fertilization in women with low ovarian reserve. |
|
|
| Not yet recruiting | 4 | 20 | Europe | Solution for injection in pre-filled syringe, Ovitrelle | Rigshospitalet, Gedeon Richter | Female Infertility, Infertility is a term doctors use if a woman hasn't been able to get pregnant after at least one year of trying., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2021-001835-22: A randomized comparison of one controlled ovarian stimulation with corifollitropin alfa (CFA) versus up to three modified natural cycles (MNC) in expected and established poor responders |
|
|
| Not yet recruiting | 4 | 300 | Europe | Solution for injection, Solution for injection in pre-filled syringe, ELONVA, Puregon, Ovitrelle, Orgalutran | Ghent University Hospital, N.V. Organon | this study will compare the efficacy of two different strategies for the management of predicted low prognosis patients under stimulation for IVF/ICSI: up to three MNCs (Modified Natural Cycle) (control group) versus a single GnRH antagonist CFA (corifollitropin alfa) (intervention group).The study population is aimed at women with a clinical indication for Assisted Reproductive Technology (ART) with an expected low response to ovarian stimulation., Subfertility, Body processes [G] - Reproductive physiologi cal processes [G08] | | | | |
| Recruiting | 4 | 165 | Europe | Triptorelin acetate (a-GnRH), Decapeptyl 0.1 mg®, Ovitrelle® (hCG), Decapeptyl 0.1 mg® (a-GnRH) and Ovitrelle® (hCG) used together | Instituto Bernabeu, Instituto Bernabeu | IVF, LOW OVARIAN RESPONSE | 12/22 | 03/23 | | |
2022-000753-80: Clinical research study to learn about the effect and safety of different doses of FE 999302 when given as a single dose for final development of the eggs after ovarian stimulation Estudio de investigación clínica para conocer el efecto y la seguridad de diferentes dosis de FE 999302 cuando se administra como dosis única para el desarrollo final de los óvulos después de la estimulación ovárica |
|
|
| Ongoing | 2 | 500 | Europe | NOVAREL, OVITRELLE, FE 999302, FE 999086, Solution for injection, Powder and solvent for solution for injection, Solution for injection in pre-filled pen, Solution for injection in pre-filled syringe, NOVAREL, OVITRELLE | Ferring Pharmaceuticals A/S, Ferring Pharmaceuticals A(S | Infertility Infertilidad, Infertility Infertilidad, Body processes [G] - Reproductive physiologi cal processes [G08] | | | | |
CS-EOSP-ICSI, NCT04071574: Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility |
|
|
| Completed | 1/2 | 200 | RoW | Human Chorionic Gonadotropin (hCG), OVITRELLE / PREGNYL, Gonadotropins, MENOPUR, GNRH-A Triptorelin, DECAPEPTYL, GnRH antagonist, CETROTIDE / ORGULATRON | Lebanese University | Female Infertility, Female Infertility Due to Ovulatory Disorder, Premature Ovarian Failure, Polycystic Ovary Syndrome, Female Infertility of Tubal Origin, Ectopic Pregnancy, Salpingitis, Female Infertility Due to Tubal Block, Female Infertility Due to Tubal Occlusion, Hydrosalpinx, Female Infertility - Cervical/Vaginal, Female Infertility Endocrine, Endometriosis, Fibroids, Congenital Uterine Anomaly, Infections Uterine, Female Infertility of Other Origin | 08/19 | 05/23 | | |
ChiCTR-IIR-16010158: A Single-Dose Study to Compare the pharmacokinetic parameters of LZM003 (T) and Ovidrel(R) using a subcutaneous injection administration in Healthy Chinese Subjects |
|
|
| Recruiting | 1 | 48 | | LZM003 (T)-Ovidrel(R) ;Ovidrel(R)-LZM003 (T) | Chinese PLA General Hospital; Livzon Mabpharm Inc., Provide by sponsor | Bioequivalence | | | | |
NCT03905603: Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS |
|
|
| Recruiting | 1 | 144 | US | ACTH, Cosyntropin, rhCG, Ovidrel | University of Virginia | Polycystic Ovary Syndrome | 04/26 | 05/26 | | |
NCT04717752: A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve |
|
|
| Recruiting | N/A | 310 | RoW | Ovidrel, Troprilin | Nanjing University | Poor Ovarian Response | 10/21 | 12/21 | | |
NCT05076981: Progesterone Levels During Ovulation and Luteal Phase |
|
|
| Completed | N/A | 6 | RoW | human chorionic gonadotropin, Ovitrelle | ART Fertility Clinics LLC | Infertility, Female | 12/21 | 12/21 | | |
NCT05969834: HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome |
|
|
| Completed | N/A | 100 | RoW | uHCG, Choriomon, rHCG, Ovitrelle, uHCG and GnRHa, Decapeptyl and Choriomon | Mansoura University | Infertility | 07/22 | 08/22 | | |
IVM-FSHhCG, NCT05370794: Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin |
|
|
| Recruiting | N/A | 35 | Europe | rhCG= Ovitrelle®, 250g/0.5ml = 26000IU/ml, Merck-Serono, rFSH = Gonal F®, 300IU/0.5ml, Merck-Serono | Universitair Ziekenhuis Brussel | In Vitro Maturation of Oocytes | 06/23 | 06/23 | | |
NCT01421810: Ovarian Contribution to Androgen Production in Adolescent Girls |
|
|
| Active, not recruiting | N/A | 80 | US | Dexamethasone, rhCG, (Ovidrel) | University of Virginia, University of California, San Diego | Polycystic Ovary Syndrome, Obesity, Hyperandrogenism | 12/25 | 12/25 | | |
